Benethera
Latest round
- Series A
Last raised
- May 2026
Total raised
- Undisclosed
Investors
- 2
About Benethera
Founded in 2021, Benethera is dedicated to developing biopharmaceutical solutions for skin inflammation diseases. The company has not undergone any significant strategic pivots and operates independently in its sector.Benethera specializes in developing and commercializing innovative biopharmaceutical products targeting autoimmune dermatological therapies. Their flagship offering is an external ointment for conditions like dermatitis, psoriasis, and eczema, designed to promote safety and efficacy through a novel pharmacological mechanism.Benethera's revenue model focuses on direct sales of its flagship ointment and related products to healthcare professionals and retail pharmacies. Revenue is generated through B2B partnerships with distributors and wholesalers, ensuring competitive pricing aligned with industry standards. The company is also planning to launch new products targeting additional autoimmune conditions and expand its market presence into untapped regions, with specific timelines for these initiatives to be defined as the company progresses.
Who invested in Benethera
2 investors across 1 round
See all investors in Benethera
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 21, 2026
Amount
Undisclosed
Investors
Questions about Benethera
Who invested in Benethera?
Benethera has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Benethera raised?
Benethera has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Benethera last raise money?
Benethera's most recent round on record is a Series A, in May 2026.
What does Benethera do?
Founded in 2021, Benethera is dedicated to developing biopharmaceutical solutions for skin inflammation diseases.
Where is Benethera headquartered?
Benethera is headquartered in Beijing, China.
Which VCs invest in companies like Benethera?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Benethera's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Benethera? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.